These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

472 related articles for article (PubMed ID: 29441052)

  • 41. API TB Consensus Guidelines 2006: Management of pulmonary tuberculosis, extra-pulmonary tuberculosis and tuberculosis in special situations.
    API Consensus Expert Committee
    J Assoc Physicians India; 2006 Mar; 54():219-34. PubMed ID: 16800350
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Lactate Metabolism and Signaling in Tuberculosis and Cancer: A Comparative Review.
    Kiran D; Basaraba RJ
    Front Cell Infect Microbiol; 2021; 11():624607. PubMed ID: 33718271
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The role of epigenetics, bacterial and host factors in progression of Mycobacterium tuberculosis infection.
    Marimani M; Ahmad A; Duse A
    Tuberculosis (Edinb); 2018 Dec; 113():200-214. PubMed ID: 30514504
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Vitamin D - A host directed autophagy mediated therapy for tuberculosis.
    Periyasamy KM; Ranganathan UD; Tripathy SP; Bethunaickan R
    Mol Immunol; 2020 Nov; 127():238-244. PubMed ID: 33039674
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Regulatory Mechanisms of Autophagy-Targeted Antimicrobial Therapeutics Against Mycobacterial Infection.
    Silwal P; Paik S; Kim JK; Yoshimori T; Jo EK
    Front Cell Infect Microbiol; 2021; 11():633360. PubMed ID: 33828998
    [No Abstract]   [Full Text] [Related]  

  • 46. Antituberculous drugs modulate bacterial phagolysosome avoidance and autophagy in Mycobacterium tuberculosis-infected macrophages.
    Genestet C; Bernard-Barret F; Hodille E; Ginevra C; Ader F; Goutelle S; Lina G; Dumitrescu O;
    Tuberculosis (Edinb); 2018 Jul; 111():67-70. PubMed ID: 30029917
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Identification and characterization of potential druggable targets among hypothetical proteins of extensively drug resistant Mycobacterium tuberculosis (XDR KZN 605) through subtractive genomics approach.
    Uddin R; Siddiqui QN; Azam SS; Saima B; Wadood A
    Eur J Pharm Sci; 2018 Mar; 114():13-23. PubMed ID: 29174549
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Stimulation through CD40 and TLR-4 Is an Effective Host Directed Therapy against
    Khan N; Pahari S; Vidyarthi A; Aqdas M; Agrewala JN
    Front Immunol; 2016; 7():386. PubMed ID: 27729911
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Therapy Of XDR TB with thioridazine a drug beyond patent protection but eligible for patent "as new use".
    Amaral L; Molnar J
    Recent Pat Antiinfect Drug Discov; 2010 Jun; 5(2):109-14. PubMed ID: 20156179
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Host sirtuin 1 regulates mycobacterial immunopathogenesis and represents a therapeutic target against tuberculosis.
    Cheng CY; Gutierrez NM; Marzuki MB; Lu X; Foreman TW; Paleja B; Lee B; Balachander A; Chen J; Tsenova L; Kurepina N; Teng KWW; West K; Mehra S; Zolezzi F; Poidinger M; Kreiswirth B; Kaushal D; Kornfeld H; Newell EW; Singhal A
    Sci Immunol; 2017 Mar; 2(9):. PubMed ID: 28707004
    [No Abstract]   [Full Text] [Related]  

  • 51. The resumption of consumption -- a review on tuberculosis.
    Ducati RG; Ruffino-Netto A; Basso LA; Santos DS
    Mem Inst Oswaldo Cruz; 2006 Nov; 101(7):697-714. PubMed ID: 17160276
    [TBL] [Abstract][Full Text] [Related]  

  • 52. An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis.
    O'Leary S; Bahlool AZ; O'Connor G; Cryan SA; Keane JM; O'Sullivan MP
    J Vis Exp; 2021 Aug; (174):. PubMed ID: 34459817
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Loperamide Restricts Intracellular Growth of Mycobacterium tuberculosis in Lung Macrophages.
    Juárez E; Carranza C; Sánchez G; González M; Chávez J; Sarabia C; Torres M; Sada E
    Am J Respir Cell Mol Biol; 2016 Dec; 55(6):837-847. PubMed ID: 27468130
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Allicin enhances antimicrobial activity of macrophages during Mycobacterium tuberculosis infection.
    Dwivedi VP; Bhattacharya D; Singh M; Bhaskar A; Kumar S; Fatima S; Sobia P; Kaer LV; Das G
    J Ethnopharmacol; 2019 Oct; 243():111634. PubMed ID: 30537531
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Identification of glucosyl-3-phosphoglycerate phosphatase as a novel drug target against resistant strain of Mycobacterium tuberculosis (XDR1219) by using comparative metabolic pathway approach.
    Uddin R; Zahra NU; Azam SS
    Comput Biol Chem; 2019 Apr; 79():91-102. PubMed ID: 30743161
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Targeting the human macrophage with combinations of drugs and inhibitors of Ca2+ and K+ transport to enhance the killing of intracellular multi-drug resistant Mycobacterium tuberculosis (MDR-TB)--a novel, patentable approach to limit the emergence of XDR-TB.
    Martins M
    Recent Pat Antiinfect Drug Discov; 2011 May; 6(2):110-7. PubMed ID: 21517742
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Inflammation-mediated tissue damage in pulmonary tuberculosis and host-directed therapeutic strategies.
    Tiwari D; Martineau AR
    Semin Immunol; 2023 Jan; 65():101672. PubMed ID: 36469987
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Anti-mycobacterial activity of some medicinal plants used traditionally by tribes from Madhya Pradesh, India for treating tuberculosis related symptoms.
    Gupta VK; Kaushik A; Chauhan DS; Ahirwar RK; Sharma S; Bisht D
    J Ethnopharmacol; 2018 Dec; 227():113-120. PubMed ID: 30172059
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Advances in immunomodulatory strategies for host-directed therapies in combating tuberculosis.
    Ayodele S; Kumar P; van Eyk A; Choonara YE
    Biomed Pharmacother; 2023 Jun; 162():114588. PubMed ID: 36989709
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Modulating Iron for Metabolic Support of TB Host Defense.
    Phelan JJ; Basdeo SA; Tazoll SC; McGivern S; Saborido JR; Keane J
    Front Immunol; 2018; 9():2296. PubMed ID: 30374347
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.